↓ Skip to main content

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

Overview of attention for article published in JACC, June 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (65th percentile)

Citations

dimensions_citation
125 Dimensions

Readers on

mendeley
127 Mendeley